T0	Participants 564 597	pregnant women infected with HIV.
T1	Participants 606 710	Pregnant women with WHO stage 1, 2, or 3 HIV-1 infection who had CD4 cell counts of 200-500 cells per Î¼L
T2	Participants 745 837	in Burkina Faso, Kenya, and South Africa to start study treatment at 28-36 weeks' gestation.
T3	Participants 1442 1453	All infants
T4	Participants 1989 2055	FINDINGS From June, 2005, to August, 2008, 882 women were enrolled
T5	Participants 2100 2143	to 805 singleton or first, liveborn infants